INCREASED THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH SYSTEMIC-SCLEROSIS AND RAYNAUD PHENOMENON

被引：0
|
作者：
REILLY, IAG [1 ]
ROY, L [1 ]
FITZGERALD, GA [1 ]
机构：
[1] VANDERBILT UNIV,DIV CLIN PHARMACOL,NASHVILLE,TN 37232
来源：
CLINICAL RESEARCH | 1986年 / 34卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A191 / A191
页数：1
相关论文
共 50 条
  • [31] INCREASED LP (A) LEVELS IN PATIENTS WITH SYSTEMIC-SCLEROSIS (SS)
    FERNANDEZCORTIJO, J
    CHACON, P
    LIMA, J
    FONOLLOSA, V
    CASTRO, A
    MARSAL, S
    SOLANS, R
    LIENCE, E
    VILARDELL, M
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 17 - 17
  • [32] Efficacy of cilostazol for the treatment of Raynaud's phenomenon in systemic sclerosis patients
    Negrini, Simone
    Spano, Francesca
    Penza, Elena
    Rollando, Daniela
    Indiveri, Francesco
    Filaci, Gilberto
    Puppo, Francesco
    CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 16 (03) : 407 - 412
  • [33] Efficacy of cilostazol for the treatment of Raynaud’s phenomenon in systemic sclerosis patients
    Simone Negrini
    Francesca Spanò
    Elena Penza
    Daniela Rollando
    Francesco Indiveri
    Gilberto Filaci
    Francesco Puppo
    Clinical and Experimental Medicine, 2016, 16 : 407 - 412
  • [34] EPIDEMIOLOGICAL STUDY FOR THE EARLY DETECTION OF SYSTEMIC SCLEROSIS IN PATIENTS WITH RAYNAUD PHENOMENON
    Beltran-Catalan, E.
    Roman-Ivorra, J. A.
    Feced, C.
    Alegre, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S75 - S75
  • [35] Sarpogrelate hydrochloride therapy for Raynaud'S phenomenon in patients with systemic sclerosis
    Ogawa, Takehiko
    Ogura, Takehisa
    Izumi, Yuichi
    Hirata, Ayako
    Hayashi, Norihide
    Miura, Reiko
    Morita, Shinobu
    Kujime, Rie
    Ogawa, Kana
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S821 - S822
  • [36] Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosis
    Hettema, M. E.
    Zhang, D.
    Bootsma, H.
    Kallenberg, C. G. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (10) : 1398 - 1399
  • [37] IMMUNOHISTOCHEMICAL LOCALIZATION OF INTRACELLULAR AND EXTRACELLULAR ASSOCIATED TGF-BETA IN THE SKIN OF PATIENTS WITH SYSTEMIC-SCLEROSIS (SCLERODERMA) AND PRIMARY RAYNAUD PHENOMENON
    GABRIELLI, A
    DILORETO, C
    TABORRO, R
    CANDELA, M
    SAMBO, P
    NITTI, C
    DANIELI, MG
    DELUSTRO, F
    DASCH, JR
    DANIELI, G
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1993, 68 (03): : 340 - 349
  • [38] PROSTACYCLIN - THROMBOXANE UNBALANCE IN SYSTEMIC-SCLEROSIS PATIENTS - A POSSIBLE ROLE IN ENDOTHELIAL DAMAGE
    LIMA, J
    FONOLLOSA, V
    FERNANDEZCORTIJO, J
    CASTRO, A
    MARSAL, S
    ROSELLO, J
    SIMEON, C
    ESPINACH, J
    ALONSO, F
    VILARDELL, M
    BRITISH JOURNAL OF RHEUMATOLOGY, 1992, 31 : 15 - 15
  • [39] Nailfold capillary abnormalities are associated with increased severity of Raynaud phenomenon among patients with systemic sclerosis: a pilot study
    Lau, Charles B.
    Smith, Gideon P.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (08) : 912 - 913
  • [40] Increased urinary pyridinoline cross-link compounds of collagen in patients with systemic sclerosis and Raynaud's phenomenon
    Istok, R
    Czirják, L
    Lukác, J
    Stancíková, M
    Rovensky, J
    RHEUMATOLOGY, 2001, 40 (02) : 140 - 146
12345